|
|||||
|
|
Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients : Results From the FEATHER Trial |
|
| Authors: | David Erlinge Jurrien ten Berg David Foley Dominick J. Angiolillo Henrik Wagner Patricia B. Brown Chunmei Zhou Junxiang Luo Joseph A. Jakubowski Brian Moser David S. Small Thomas Bergmeijer Stefan James Kenneth J. Winters |
| Affiliation: | ? Department of Cardiology, Lund University, Lund, Sweden;† Department of Cardiology, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands;‡ Clinical Research Centre, Dublin, Ireland;§ Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida;∥ Eli Lilly and Co., Indianapolis, Indiana;¶ Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala, Sweden |
| Abstract: | |
| Keywords: | coronary artery disease low body weight platelet reactivity prasugrel |
| 本文献已被 ScienceDirect 等数据库收录！ | |